Clin2
NCT07535996Likely a fitNot yet recruiting

Diet and Muscle Health Study for Inclusion Body Myositis

Inclusion Body Myositis

Part of Bones, joints & muscles, Brain & nervous system clinical trials.

This research study examines how diet relates to muscle disease in people with inclusion body myositis (IBM), a rare muscle-weakening condition. Researchers will compare eating habits and nutritional patterns between people with IBM and healthy volunteers to understand how nutrition affects muscle health.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
47 people
Ages
40 years and older
Study type
Observational

Who can take part

  • Confirmed diagnosis of inclusion body myositis (IBM) using standard diagnostic criteria, or you are a healthy control participant
  • Age 40 or older
  • Able to walk short distances (with or without a cane, walker, or other aid)
  • Able to eat solid or soft foods (not requiring only tube feeding)
  • Able to understand English well enough to provide consent and follow study procedures
  • Not currently enrolled in another medical research study, or not enrolled in one within the past 3 months

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT00017914Recruiting
Understanding muscle inflammation: adult and juvenile myositis study

This research study helps doctors better understand myositis—a group of rare diseases that cause muscle inflammation and weakness. Researchers collect blood samples, medical history, and sometimes muscle biopsies to learn more about what causes these conditions and how to treat them better.

Atlanta, Georgia
NCT07374107Recruiting
Patient insights for shaping myositis research

This study asks people with autoimmune muscle diseases (myositis) and their caregivers to share their experiences and insights. By joining, you help shape better research and care for myositis.

New Orleans, Louisiana
NCT06536166Recruiting· Phase 2
Ruxolitinib for Inclusion Body Myositis

This trial tests the drug ruxolitinib (a JAK inhibitor) for people with inclusion body myositis (IBM), a progressive muscle disease. It aims to see if ruxolitinib can help slow muscle weakness and improve function.

Angers, France
NCT07502989Recruiting
Study of Muscle Health Using Electrical Impedance Myography

This study uses a simple electrical test (EIM) and an MRI scan to check muscle health in people with muscle diseases. It may help researchers learn how to measure muscle changes without a biopsy.

Boston, Massachusetts
NCT07552220Not yet recruiting
Muscle Imaging Study Using Advanced Scanning Technology

This research project uses advanced imaging and tissue sampling to better understand muscle diseases. If you're already having a muscle biopsy (a small tissue sample taken from your muscle) as part of your regular medical care, researchers want to use that sample to test new imaging methods that might help diagnose muscle problems more accurately in the future.

Mâcon
NCT07362875Recruiting
Muscle imaging study for myotonic dystrophy

This study uses MRI scans to measure muscle changes in people with myotonic dystrophy (DM1 or DM2) and healthy volunteers. The goal is to find better ways to track the disease over time.

Winston-Salem, North Carolina

Hear when a new Inclusion Body Myositis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.